Energy-Based Devices for Exogenous Ochronosis: A Systematic Review of Randomized Controlled Trials and Primary Studies
Abstract
Introduction
Exogenous ochronosis (EO) is an acquired cutaneous disorder characterized by progressive dermal hyperpigmentation resulting from prolonged topical hydroquinone exposure. The deeply deposited ochronotic pigment within dermal collagen renders conventional therapies ineffective. Energy-based devices (EBDs) have emerged as the primary interventional strategy. This systematic review synthesizes evidence on EBD efficacy, safety, and patient-reported outcomes for EO treatment.
Methods
This systematic review followed PRISMA 2020 guidelines. A comprehensive search was conducted from inception to June 2025. Studies evaluating any EBD for confirmed EO with quantifiable outcomes were included. Risk of bias was assessed using Newcastle-Ottawa Scale and Cochrane RoB-2 tools.
Results
Fifteen primary studies (147 patients) were included. Q-switched alexandrite (755 nm) laser achieved 85–100% pigment clearance after 4–6 sessions. Q-switched Nd:YAG (1064 nm) and picosecond lasers demonstrated excellent outcomes in Fitzpatrick skin types III–VI. Combination therapies showed synergistic benefit in refractory cases. Adverse events were predominantly mild and transient.
Discussion
EBDs exploit selective photothermolysis to fragment dermal ochronotic pigment. Q-switched alexandrite remains the most validated monotherapy, while picosecond technologies offer superior precision with lower post-inflammatory hyperpigmentation rates. Significant heterogeneity and absence of standardized…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 147 participants or records.
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.